Document is current
Any future updates will be listed below
-
Authors
Briggs, Logan G. https://orcid.org/0000-0001-6406-5784
Reese, Stephen
Herzog, Peter
Nguyen, David-Dan
Labban, Muhieddine https://orcid.org/0000-0002-4580-1915
Alkhatib, Khalid https://orcid.org/0000-0002-6008-0503
Trinh, Quoc-Dien
Morgans, Alicia K. https://orcid.org/0000-0002-6563-4587
- License Information
-
More Information
Article History
Received: 20 November 2021
Revised: 18 March 2022
Accepted: 1 April 2022
First Online: 18 April 2022
Competing interests
: The authors have no competing interests to disclose. QDT reports personal fees from Astellas, Bayer and Janssen, outside the submitted work. QDT reports research funding from the American Cancer Society, the Defense Health Agency, Pfizer Global Medical Grants. AKM reports personal fees from Astellas, AstraZeneca, Advanced Accelerator Applications, Bayer, Clovis, Dendreon, Exelixis, Myovant, Novartis, Pfizer, Sanofi, Blue Earth, Lantheus, and Myriad. LGB reports consulting fees from Delfina outside of the submitted work and research funding from the Office of Scholarly Engagement at Harvard Medical School. All other authors have nothing to disclose.
